China SXT Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended March 31, 2022
July 18, 2022 at 04:01 pm
China SXT Pharmaceuticals, Inc. reported earnings results for the full year ended March 31, 2022. For the full year, the company reported sales was USD 2.6 million compared to USD 4.78 million a year ago. Revenue was USD 2.6 million compared to USD 4.78 million a year ago. Net loss was USD 5.74 million compared to USD 2.75 million a year ago. Basic loss per share from continuing operations was USD 5.517 compared to USD 3.819 a year ago.